Margarida Duarte
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Margarida Duarte is currently an Independent Director at Egetis Therapeutics AB since 2025 and serves as Global Chief Commercial Officer & Executive VP at Deciphera Pharmaceuticals, Inc. Formerly, Ms. Duarte was Vice President & Head-Commercial Canada at Alnylam Pharmaceuticals, Inc. Education includes graduate studies at ISCTE-Instituto Universitário de Lisboa and undergraduate studies at the University of Lisbon.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EGETIS THERAPEUTICS AB | Directeur/Bestuurslid | 01-01-2025 |
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
ISCTE-Instituto Universitário de Lisboa
ISCTE-Instituto Universitário de Lisboa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lisbon
University of Lisbon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau